期刊文献+

桂枝茯苓丸治疗子宫肌瘤并发乳腺增生临床研究 被引量:4

Clinical Research on Hysteromyoma Complicated with Hyperplasia of Mammary Glands Treated with Guizhi Fuling Pill
下载PDF
导出
摘要 目的:观察桂枝茯苓丸治疗子宫肌瘤并发乳腺增生的临床疗效。方法:选取本院2013年4月—2014年12月收治的88例子宫肌瘤并发乳腺增生患者,随机分为研究组和对照组各44例。对照组给予逍遥丸治疗,研究组给予桂枝茯苓丸治疗。观察两组患者治疗前后E2、P、LDL、TG、TC、ER及PR等生化指标的变化。结果:研究组痊愈18例,显效16例,有效8例,无效2例,有效率为95.5%,对照组痊愈10例,显效14例,有效13例,无效7例,有效率为84.1%,差异有统计学意义(P<0.05)。两组患者治疗后切变率、血浆黏度、E2、P、LDL、TG及TC值较治疗前均明显改善(P<0.05),组间比较差异显著(P<0.05)。结论:桂枝茯苓丸治疗子宫肌瘤并发乳腺增生疗效显著。 Objective: To observe the clinical effects of Guizhi Fuling Pill on hysteromyoma complicated with hyperplasia of mam- mary. glands. Methods: 88 cases with hysteromyoma complicated with hyperplasia of mammary glands received by this hospital from April of 2013 to December of 2014 were randomized into research group and control group, with 44 cases in each group. Control group were given Free-Wandering Pill for the treatment while research group were given Guizhi Fuling Pill for the treat- ment. The changes of the biochemical indexes of E2, P, LDL, TG, TC, ER and PR in both groups after the treatment were ob- served. Results: In research group, 18 cases were cured, 16 cases markedly improved; 8 cases improved and 2 cases showed no effects; the effective rate was 95.5%. In control group, l0 cases were cured, 14 cases markedly improved; 13 cases improved and 7 cases showed no effects ; the effective rate was 84.1% ; the difference had statistical significance ( P 〈 0.05 ). After the treatment, the shear rate, viscosity of plasma, values of E2, P, LDL, TG and TC all got improved ( P 〈 0.05 ) ; there was signif- icant difference between the two groups ( P 〈 0. 05 ). Conclusion : Guizhi Fuling Pill has reamarkable therapeutic effects on hyste- romyoma complicated with hyperplasia of mammary glands.
作者 刘小萍
机构地区 泰兴市中医院
出处 《河南中医》 2015年第11期2603-2604,共2页 Henan Traditional Chinese Medicine
关键词 子宫肌瘤 乳腺增生 桂枝茯苓丸 《金匮要略》 张仲景 hysteromyoma hyperplasia of mammary, glands Guizhi Fuling Pill Synopsis of Golden Chamber Zhang Zhongjing
  • 相关文献

参考文献8

二级参考文献75

  • 1林嫒妮,黄雅,桂华.桂枝茯苓胶囊联合米非司酮治疗子宫肌瘤的实验研究[J].求医问药(下半月刊),2012,10(12). 被引量:3
  • 2柳素青.米非司酮联合桂枝茯苓胶囊治疗子宫肌瘤58例[J].福建中医药,2013,44(1):35-36. 被引量:9
  • 3梅和珊,王永利.脑缺血时谷氨酸释放机制[J].中国药理学通报,2005,21(4):393-396. 被引量:38
  • 4曾芹.中西医结合治疗子宫肌瘤及卵巢囊肿的临床观察[J].中国血液流变学杂志,2005,15(4):638-639. 被引量:8
  • 5肖承惊.中医妇科临床研究.北京:人民卫生出版社.2009:233.
  • 6Dikareva LV, shvarev EG,shvarev GE,et aI.Age,structural and biochemical characteristics ofendometrial secretion in patients with hysteromyoma[J].Adv Gerontol,2008.21 (4):596-601.
  • 7郑筏萸.中药新药临床研究指导原则[M].2002版.北京:中国医药科技出版社,2002,234-235.
  • 8Zaleska MM,Mercado mL,Chavez J,et al. The de- velopment of stroke therapeutics : promising mechanisms and translational challen-ges[J]. Neuropharmacology, 2009,56 ( 2 ) :329-341.
  • 9陈爱英,郑书珍,王义.子宫腺肌病的B超诊断与子宫肌瘤的监别[J].中国临床医药杂志研究,2006,153(2):68-70.
  • 10Rune A, Huglund AL, Hestvik T, et al . Expres- sion and functional activity of chemokine receptors in glatiramer acetate-specific T cells isolated from multiple sclerosis patient receiving the drug glatiramer acetate[J]. Human immunology, 2011,72(2) :55-56.

共引文献120

同被引文献41

引证文献4

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部